Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00070083
Status:
COMPLETED
Last Update Posted:
2009-04-07
First Post:
2003-10-03
Brief Title:
Oblimersen Rituximab Cyclophosphamide Doxorubicin Vincristine and Prednisone in Treating Patients With Stage II Stage III or Stage IV Diffuse Large B-Cell Lymphoma
Sponsor:
British Columbia Cancer Agency
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000329985
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
British Columbia Cancer Agency
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |